dc.contributor.author
Winterhalter, Sibylle
dc.contributor.author
vom Brocke, Gerrit Alexander
dc.contributor.author
Pilger, Daniel
dc.contributor.author
Eckert, Annabelle
dc.contributor.author
Schlomberg, Juliane
dc.contributor.author
Ruebsam, Anne
dc.contributor.author
Klamann, Matthias Karl
dc.contributor.author
Gundlach, Enken
dc.contributor.author
Dietrich-Ntoukas, Tina
dc.contributor.author
Joussen, Antonia Maria
dc.date.accessioned
2018-06-08T10:18:15Z
dc.date.available
2016-11-28T13:13:55.953Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/20210
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-23516
dc.description.abstract
Background Patients with initially low visual acuity were excluded from the
therapy approval studies for retinal vein occlusion. But up to 28 % of
patients presenting with central retinal vein occlusion have a baseline BCVA
of less than 34 ETDRS letters (0.1). The purpose of our study was to assess
visual acuity and central retinal thickness in patients suffering from central
retinal vein occlusion and low visual acuity (<0.1) in comparison to patients
with visual acuity (≥0.1) treated with Dexamethasone implant 0.7 mg for
macular edema. Methods Retrospective, controlled observational case study of
30 eyes with macular edema secondary to central retinal vein occlusion, which
were treated with a dexamethasone implantation. Visual acuity, central retinal
thickness and intraocular pressure were measured monthly. Analyses were
performed separately for eyes with visual acuity <0.1 and ≥0.1. Results Two
months post intervention, visual acuity improved only marginally from 0.05 to
0.07 (1 month; p = 0,065) and to 0.08 (2 months; p = 0,2) in patients with low
visual acuity as compared to patients with visual acuity ≥0.1 with an
improvement from 0.33 to 0.47 (1 month; p = 0,005) and to 0.49 (2 months; p =
0,003). The central retinal thickness, however, was reduced in both groups,
falling from 694 to 344 μm (1 month; p = 0.003,) to 361 μm (2 months; p =
0,002) and to 415 μm (3 months; p = 0,004) in the low visual acuity group and
from 634 to 315 μm (1 month; p < 0,001) and to 343 μm (2 months; p = 0,001) in
the visual acuity group ≥0.1. Absence of visual acuity improvement was related
to macular ischemia. Conclusions In patients with central retinal vein
occlusion and initially low visual acuity, a dexamethasone implantation can
lead to an important reduction of central retinal thickness but may be of
limited use to increase visual acuity.
en
dc.rights.uri
http://creativecommons.org/licenses/by/4.0/
dc.subject
Central retinal vein occlusion
dc.subject
Corticosteroids
dc.subject
Intravitreal dexamethasone implant Macular edema
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit
dc.title
Retrospective, controlled observational case study of patients with central
retinal vein occlusion and initially low visual acuity treated with an
intravitreal dexamethasone implant
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
BMC Ophthalmology. - 16 (2016), Artikel Nr. 187
dcterms.bibliographicCitation.doi
10.1186/s12886-016-0363-5
dcterms.bibliographicCitation.url
http://doi.org/10.1186/s12886-016-0363-5
refubium.affiliation
Charité - Universitätsmedizin Berlin
de
refubium.mycore.fudocsId
FUDOCS_document_000000025938
refubium.note.author
Der Artikel wurde in einer reinen Open-Access-Zeitschrift publiziert.
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000007385
dcterms.accessRights.openaire
open access